Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription

Parkinson’s disease (PD) is characterized by loss of A9 dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). An association has been reported between PD and exposure to mitochondrial toxins, including environmental pesticides paraquat, maneb, and rotenone. Here, using a robust, patient-derived stem cell model of PD allowing comparison of A53T α-synuclein (α-syn) mutant cells and isogenic mutation-corrected controls, we identify mitochondrial toxin-induced perturbations in A53T α-syn A9 DA neurons (hNs). We report a pathway whereby basal and toxin-induced nitrosative/oxidative stress results in S-nitrosylation of transcription factor MEF2C in A53T hNs compared to corrected controls. This redox reaction inhibits the MEF2C-PGC1α transcriptional network, contributing to mitochondrial dysfunction and apoptotic cell death. Our data provide mechanistic insight into gene-environmental interaction (GxE) in the pathogenesis of PD. Furthermore, using small-molecule high-throughput screening, we identify the MEF2C-PGC1α pathway as a therapeutic target to combat PD.

[1]  Susan Lindquist,et al.  Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations , 2011, Cell.

[2]  G. Fishman,et al.  Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha ) and mitochondrial function by MEF2 and HDAC5. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Lipton,et al.  MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Sidhu,et al.  Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia , 2010, Experimental Neurology.

[5]  Paul T. Schumacker,et al.  Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1 , 2010, Nature.

[6]  J. Trojanowski,et al.  Pesticide Exposure Exacerbates α-Synucleinopathy in an A53T Transgenic Mouse Model , 2007 .

[7]  Jiankun Cui,et al.  Myocyte Enhancer Factor 2C as a Neurogenic and Antiapoptotic Transcription Factor in Murine Embryonic Stem Cells , 2008, The Journal of Neuroscience.

[8]  M. Ronaghi,et al.  Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data , 2010, PloS one.

[9]  J. M. Fuentes,et al.  Nitric oxide in paraquat‐mediated toxicity: A review , 2010, Journal of biochemical and molecular toxicology.

[10]  T. Richmond,et al.  Crystal structure of MEF2A core bound to DNA at 1.5 A resolution. , 2000, Journal of molecular biology.

[11]  Sheng Ding,et al.  A chemical platform for improved induction of human iPSCs , 2009, Nature Methods.

[12]  J. Stamler,et al.  Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.

[13]  Stuart A. Lipton,et al.  Aberrant Protein S-Nitrosylation in Neurodegenerative Diseases , 2013, Neuron.

[14]  G. Fishman,et al.  Regulation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Vicencio,et al.  PGC-1 family coactivators and cell fate: roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signalling. , 2012, Mitochondrion.

[16]  G M Clore,et al.  Solution structure of the MEF2A–DNA complex: structural basis for the modulation of DNA bending and specificity by MADS‐box transcription factors , 2000, The EMBO journal.

[17]  D. Liebler,et al.  Provided for Non-commercial Research and Educational Use Only. Not for Reproduction, Distribution or Commercial Use. Use of Dimedone-based Chemical Probes for Sulfenic Acid Detection: Methods to Visualize and Identify Labeled Proteins Author's Personal Copy , 2022 .

[18]  E. Masliah,et al.  The many faces of α-synuclein: from structure and toxicity to therapeutic target , 2012, Nature Reviews Neuroscience.

[19]  Jiandie D. Lin,et al.  An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Masliah,et al.  Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson’s disease , 2012, Molecular Neurodegeneration.

[21]  D. Price,et al.  Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation , 2004, The Journal of Neuroscience.

[22]  A. Navarro,et al.  Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome. , 2007, Frontiers in bioscience : a journal and virtual library.

[23]  Petteri Piepponen,et al.  Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease , 2011, Cellular and Molecular Life Sciences.

[24]  Jiankun Cui,et al.  Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Y. Smith,et al.  Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients. , 2011, The Journal of clinical investigation.

[26]  E. Richfield,et al.  The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease , 2000, The Journal of Neuroscience.

[27]  Jeffrey D. Zaremba,et al.  Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo , 2008, Proceedings of the National Academy of Sciences.

[28]  Blake Byers,et al.  LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. , 2011, Cell stem cell.

[29]  J. Trojanowski,et al.  Phosphorylated α-Synuclein in Parkinson’s Disease , 2012, Science Translational Medicine.

[30]  Eric J. Toone,et al.  (S)NO Signals: Translocation, Regulation, and a Consensus Motif , 1997, Neuron.

[31]  J. Yates,et al.  DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. , 2002, Journal of proteome research.

[32]  S. Lipton,et al.  Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death. , 2010, Molecular cell.

[33]  D. Sulzer,et al.  Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons , 2009, Neuron.

[34]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[35]  S. Lipton,et al.  Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex , 1992, Neuron.

[36]  D. D. Di Monte,et al.  Toxicity of redox cycling pesticides in primary mesencephalic cultures. , 2005, Antioxidants & redox signaling.

[37]  Eric K. Richfield,et al.  Risk factors for dopaminergic neuron loss in human α‐synuclein transgenic mice , 2004 .

[38]  D. Surmeier,et al.  Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD , 2011, Nature.

[39]  K. Matsubara,et al.  Carrier-mediated processes in blood–brain barrier penetration and neural uptake of paraquat , 2001, Brain Research.

[40]  Takashi Uehara,et al.  S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration , 2006, Nature.

[41]  Takashi Uehara,et al.  Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Jiankun Cui,et al.  S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.

[43]  Joseph Loscalzo,et al.  A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds , 1993, Nature.

[44]  D. D. Di Monte,et al.  Oxidative and nitrative alpha‐synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies , 2013, Journal of neurochemistry.

[45]  D. Simon,et al.  Transcribe to survive: transcriptional control of antioxidant defense programs for neuroprotection in Parkinson's disease. , 2009, Antioxidants & redox signaling.

[46]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[47]  Paul Tempst,et al.  Protein S-nitrosylation: a physiological signal for neuronal nitric oxide , 2001, Nature Cell Biology.

[48]  J. Trojanowski,et al.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. , 2000, Science.

[49]  Christine Klein,et al.  Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease , 2012, Science Translational Medicine.

[50]  Beate Ritz,et al.  Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. , 2009, American journal of epidemiology.

[51]  P. Bross,et al.  Protein misfolding and cellular stress: an overview. , 2010, Methods in molecular biology.

[52]  S. Lipton,et al.  Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[53]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[54]  A. Godzik,et al.  S-Nitrosylation of Drp1 Mediates β-Amyloid-Related Mitochondrial Fission and Neuronal Injury , 2009, Science.

[55]  Jeffrey D. Zaremba,et al.  MEF2C Enhances Dopaminergic Neuron Differentiation of Human Embryonic Stem Cells in a Parkinsonian Rat Model , 2011, PloS one.

[56]  Manuel B. Graeber,et al.  PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease , 2010, Science Translational Medicine.

[57]  G. Lyons,et al.  Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[58]  I. Bezprozvanny,et al.  Small-molecule activation of neuronal cell fate. , 2008, Nature chemical biology.

[59]  J. Souza,et al.  Oxidation and nitration of α-synuclein and their implications in neurodegenerative diseases. , 2013, Archives of biochemistry and biophysics.

[60]  A. Miranker,et al.  Protein-induced photophysical changes to the amyloid indicator dye thioflavin T , 2010, Proceedings of the National Academy of Sciences.

[61]  Jiandie D. Lin,et al.  An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Krishanu Saha,et al.  Technical challenges in using human induced pluripotent stem cells to model disease. , 2009, Cell stem cell.

[63]  M E Greenberg,et al.  Neuronal activity-dependent cell survival mediated by transcription factor MEF2. , 1999, Science.